{"id":"https://openalex.org/W2109727303","doi":"https://doi.org/10.1517/13543784.2014.942034","title":"Vandetanib as a potential treatment for breast cancer","display_name":"Vandetanib as a potential treatment for breast cancer","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-04","ids":{"openalex":"https://openalex.org/W2109727303","doi":"https://doi.org/10.1517/13543784.2014.942034","mag":"2109727303","pmid":"https://pubmed.ncbi.nlm.nih.gov/25089348"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2014.942034","doi":"https://doi.org/10.1517/13543784.2014.942034","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.942034","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109727303"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013429068","display_name":"Antonella De Luca","orcid":"https://orcid.org/0000-0001-5762-447X","observed_orcids":["https://orcid.org/0000-0001-5762-447X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonella De Luca","raw_affiliation_strings":["Istituto Nazionale Tumori \"Fondazione G. Pascale\" - IRCCS, Cell Biology and Biotherapy Unit , Via Mariano Semmola 80131, Naples , Italy +39 081 5903826 ; antoneldel@hotmail.com , a.deluca@istitutotumori.na.it","Istituto Nazionale Tumori Fondazione G. Pascale - IRCCS, Cell Biology and Biotherapy Unit , Via Mariano Semmola 80131, Naples , Italy +39 081 5903826 ;  ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \"Fondazione G. Pascale\" - IRCCS, Cell Biology and Biotherapy Unit , Via Mariano Semmola 80131, Naples , Italy +39 081 5903826 ; antoneldel@hotmail.com , a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"Istituto Nazionale Tumori Fondazione G. Pascale - IRCCS, Cell Biology and Biotherapy Unit , Via Mariano Semmola 80131, Naples , Italy +39 081 5903826 ;  ,","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103435993","display_name":"Amelia D\u2019Alessio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Amelia D\u2019Alessio","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089331461","display_name":"Monica Rosaria Maiello","orcid":"https://orcid.org/0000-0002-6670-4110","observed_orcids":["https://orcid.org/0000-0002-6670-4110"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Rosaria Maiello","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004690523","display_name":"Marianna Gallo","orcid":"https://orcid.org/0000-0001-9098-5779","observed_orcids":["https://orcid.org/0000-0001-9098-5779"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marianna Gallo","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062023516","display_name":"Simona Bevilacqua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Bevilacqua","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049567032","display_name":"Daniela Frezzetti","orcid":"https://orcid.org/0000-0002-7500-5506","observed_orcids":["https://orcid.org/0000-0002-7500-5506"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniela Frezzetti","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051933262","display_name":"Alessandro Morabito","orcid":"https://orcid.org/0000-0002-1319-9608","observed_orcids":["https://orcid.org/0000-0002-1319-9608"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Morabito","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Medical Oncology Unit, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Medical Oncology Unit, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015740152","display_name":"Federica Perrone","orcid":"https://orcid.org/0000-0003-4406-8245","observed_orcids":["https://orcid.org/0000-0003-4406-8245","https://orcid.org/0009-0008-4469-3386"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Perrone","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Clinical Trials Unit, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Clinical Trials Unit, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003014678","display_name":"Nicola Normanno","orcid":"https://orcid.org/0000-0002-7158-2605","observed_orcids":["https://orcid.org/0000-0002-7158-2605"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Normanno","raw_affiliation_strings":["Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d \u2013 IRCCS, Cell Biology and Biotherapy Unit, Via Mariano Semmola 80131, Naples, Italy +39 081 5903826; antoneldel@hotmail.com, a.deluca@istitutotumori.na.it","institution_ids":["https://openalex.org/I4210141868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210141868"],"apc_list":null,"apc_paid":null,"fwci":0.1499,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.09155107,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"23","issue":"9","first_page":"1295","last_page":"1303"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.902999997138977},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8100000023841858},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.9160000085830688},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8930000066757202},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8899999856948853},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.890999972820282},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.9883509874343872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7786272764205933},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6535532474517822},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5927236676216125},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5594108700752258},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5406022667884827},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5263841152191162},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4883989691734314},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.473538339138031},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45882749557495117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44745415449142456},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.437299907207489},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3442500829696655},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17104509472846985}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.2014.942034","doi":"https://doi.org/10.1517/13543784.2014.942034","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.942034","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:25089348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25089348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1562056707","https://openalex.org/W1665704747","https://openalex.org/W1963655681","https://openalex.org/W1969482148","https://openalex.org/W1969692667","https://openalex.org/W1969903270","https://openalex.org/W1971969583","https://openalex.org/W1977999028","https://openalex.org/W1988055795","https://openalex.org/W1988607961","https://openalex.org/W1989401206","https://openalex.org/W2000292756","https://openalex.org/W2012565837","https://openalex.org/W2014383618","https://openalex.org/W2021399951","https://openalex.org/W2030722611","https://openalex.org/W2051877908","https://openalex.org/W2056031639","https://openalex.org/W2058413420","https://openalex.org/W2062316437","https://openalex.org/W2068852196","https://openalex.org/W2070743887","https://openalex.org/W2079127064","https://openalex.org/W2081887573","https://openalex.org/W2084740377","https://openalex.org/W2085053752","https://openalex.org/W2087523741","https://openalex.org/W2102540838","https://openalex.org/W2104374675","https://openalex.org/W2106955083","https://openalex.org/W2111060860","https://openalex.org/W2111870457","https://openalex.org/W2118559000","https://openalex.org/W2121566802","https://openalex.org/W2121946731","https://openalex.org/W2123177825","https://openalex.org/W2125916043","https://openalex.org/W2127809030","https://openalex.org/W2131705241","https://openalex.org/W2139387145","https://openalex.org/W2145854263","https://openalex.org/W2147107643","https://openalex.org/W2165708858","https://openalex.org/W2169965478","https://openalex.org/W2590446817","https://openalex.org/W2737220576","https://openalex.org/W4252851641"],"related_works":["https://openalex.org/W2083650117","https://openalex.org/W2135081135","https://openalex.org/W2902921624","https://openalex.org/W2052796007","https://openalex.org/W7223282931","https://openalex.org/W1985027324","https://openalex.org/W6930170050","https://openalex.org/W2517800231","https://openalex.org/W4308415649","https://openalex.org/W2147289344"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,41,56,132],"VEGF":[2],"A":[3],"/VEGF":[4],"receptor":[5],"(VEGFR)":[6],"network":[7],"actively":[8],"contributes":[9],"to":[10,71,125,157,173,180,182],"breast":[11,52,102,130],"cancer":[12],"pathogenesis":[13],"and":[14,37,65,77,83,86,122,142],"progression,":[15],"playing":[16],"a":[17,26,95],"pivotal":[18],"role":[19],"in":[20,48,98,128,136,143,155],"promoting":[21],"tumour-associated":[22],"angiogenesis.":[23],"Vandetanib":[24,92],"is":[25],"multitargeted":[27],"tyrosine":[28,39],"kinase":[29],"inhibitor":[30],"that":[31],"selectively":[32],"blocks":[33],"VEGFR-2,":[34],"the":[35,59,75,78,81,87,107,120,126,140,159,163,166],"EGFR":[36],"RET":[38],"kinases.":[40],"drug":[42,127],"has":[43,93],"shown":[44],"promising":[45],"anti-tumour":[46],"activity":[47,133],"preclinical":[49,64],"models":[50],"of":[51,68,110,134,139,162,168],"cancer.":[53,103,131],"AREAS":[54],"COVERED:":[55],"authors":[57],"summarise":[58],"data":[60],"on":[61],"pharmacodynamics,":[62],"pharmacokinetics,":[63],"clinical":[66,160],"studies":[67],"vandetanib":[69,135],"up":[70],"April":[72],"2014,":[73],"using:":[74],"PubMed":[76],"clinicaltrials.gov":[79],"databases;":[80],"FDA":[82],"EMA":[84],"websites":[85],"ASCO":[88],"proceedings.":[89],"EXPERT":[90],"OPINION:":[91],"demonstrated":[94],"modest":[96],"efficacy":[97,161],"patients":[99,175],"with":[100,145],"metastatic":[101],"In":[104],"this":[105],"respect,":[106],"increased":[108],"number":[109],"angiogenic":[111],"pathways":[112],"activated":[113],"during":[114],"tumour":[115],"progression":[116],"might":[117,171],"partially":[118],"explain":[119],"intrinsic":[121],"acquired":[123],"resistance":[124],"advanced":[129],"early":[137],"phases":[138],"disease,":[141],"combination":[144],"other":[146],"anti-angiogenic":[147,183],"factors":[148],"or":[149],"metronomic":[150],"therapy,":[151],"should":[152],"be":[153],"explored":[154],"order":[156],"improve":[158],"drug.":[164],"Finally,":[165],"identification":[167],"predictive":[169],"markers":[170],"help":[172],"select":[174],"who":[176],"are":[177],"more":[178],"likely":[179],"respond":[181],"drugs.":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2109727303","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
